Who
Jose-Carlos Gutierrez-Ramos
SVP, Chief Science Officer
Company insider
Files Form 4 as: SVP, Chief Science Officer, Danaher; Director, Bicycle Therapeutics; Director, Evelo Biosciences; Director, Momenta Pharmaceuticals; Director and Officer, Synlogic.
In numbers
- Trades disclosed
- 83
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $1.1M
- Companies
- 5
- Companies where not an officer
- 3
- First trade
- 9 Mar 2016
- Last trade
- 4 Aug 2026
- Last filed
- 6 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Aug 2026filed 6 Aug 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code A | —13,477 at $0.00 | filing |
| 4 Aug 2026filed 6 Aug 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code A | —13,477 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code A | —6,647 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code F | $60K284 at $210.64 | filing |
| 1 Mar 2026filed 3 Mar 2026 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | —17,964 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | —17,964 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code A | —6,647 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code F | $60K284 at $210.64 | filing |
| 24 Feb 2026filed 25 Feb 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code F | $72K344 at $209.19 | filing |
| 24 Feb 2026filed 25 Feb 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code F | $72K344 at $209.19 | filing |
| 4 Feb 2026filed 6 Feb 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code A | —1,695 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code A | —1,695 at $0.00 | filing |
| 2 Feb 2026filed 4 Feb 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code F | $190K852 at $223.42 | filing |
| 2 Feb 2026filed 4 Feb 2026 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | $60K275 at $218.89 | filing |
| 2 Feb 2026filed 4 Feb 2026 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | $60K275 at $218.89 | filing |
| 2 Feb 2026filed 4 Feb 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code F | $190K852 at $223.42 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —9,500 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —9,500 at $0.00 | filing |
News
Roper Technologies (ROP) vs. Danaher (DHR): Which Is the Better Long-Term Capital Allocator?DHR · insidermonkey.com · 18 Oct 2026Willow Creek Capital Management Inc. Purchases 2,796 Shares of Danaher Corporation $DHRDHR · dailypolitical.com · 17 Oct 2026Danaher's Stock Is Pricing in a Recovery. Can Its Earnings Deliver?DHR · insidermonkey.com · 16 Oct 2026
0 headlines in the last 90 days name Jose-Carlos Gutierrez-Ramos; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.